BioSpace News Archive

Cell and Gene Therapy Market Size Worth USD 6.57 Million By 2027 | Emergen Research

The global Cell and Gene Therapy Market is expected to reach USD 6,570.0 Million by 2027, according to a new report by Emergen Research.

August 3, 2022
·
5 min read
Advanced Proteome Therapeutics Receives Issued Patent

On August 2, 2022, APTI was issued U.S. Patent No. 11,400,165 titled ‘Composition and method for modifying polypeptides’.

August 3, 2022
·
4 min read
Business

Adaptive Biotechnologies Reports Second Quarter 2022 Financial Results

Adaptive Biotechnologies Corporation, a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, reported financial results for the quarter ended June 30, 2022.

August 3, 2022
·
8 min read
Kiniksa Pharmaceuticals to Present at 2022 Wedbush PacGrow Healthcare Conference

Kiniksa Pharmaceuticals, Ltd. announced that its management will participate in a fireside chat at the 2022 Wedbush PacGrow Healthcare Conference on Tuesday, August 9, 2022 at 2:55 p.m. Eastern Time.

August 3, 2022
·
1 min read
Business

Fate Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Operational Progress

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, reported business highlights and financial results for the second quarter ended June 30, 2022.

August 3, 2022
·
27 min read
Business

Paratek Pharmaceuticals Announces Second Quarter 2022 Revenue of $29.6 Million

Paratek Pharmaceuticals, Inc., reported financial results and provided an update on corporate activities for the quarter ended June 30, 2022.

August 3, 2022
·
10 min read
Business

Cognition Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022

Cognition Therapeutics, Inc. announced that it will report financial results for the second quarter ended June 30, 2022, in the form of a press release before the financial markets open on Tuesday, August 9, 2022.

August 3, 2022
·
3 min read
Business

Inari Medical Reports Second Quarter 2022 Financial Results

Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, reported financial results for its second quarter ended June 30, 2022.

August 3, 2022
·
7 min read
Business

Nabriva Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

Nabriva Therapeutics plc, a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, announced its financial results for the three months ended June 30, 2022 and provided a corporate update.

August 3, 2022
·
15 min read
Biotech Beach

Poseida Therapeutics Announces Proposed Public Offering of Common Stock - Aug 03, 2022

Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, announced that it has commenced an underwritten public offering of shares of its common stock.

August 3, 2022
·
4 min read